IP Library › Granted Patent US 12,540,277
Granted Patent B2
US 12,540,277 · App. 17/658,664 · Granted Feb 3, 2026

Water-based curable composition for production of coatings comprising phosphors

Inventors: Simone Schulte (Essen, DE); Markus Hallack (Schermbeck, DE); Michael Huth (Maintal, DE); Juri Tschernjaew (Aschaffenburg, DE); Stefan Fischer (Soest, DE); Thomas Jüstel (Witten, DE); Franziska Schröder (Steinfurt, DE); Sven Reetz (Gronau, DE)
Assignee: Evonik Operations GmbH
C09K11/77062C09D5/14C09D5/22C09D7/61C08K3/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,277
App. No.
17/658,664
Granted
Feb 3, 2026
Kind
B2
Abstract

A water-based curable composition, for production of coatings having an antimicrobial property, contains at least one film-forming polymer, optionally at least one additive and/or at least one curing agent, and at least one up-conversion phosphor of the general formula (I): A 1-x-y-z B* y B 2 SiO 4 :Ln 1 x ,Ln 2 z . In the general formula (I), x=0.0001-0.0500; z=0.0000 or z=0.0001 to 0.3000 with the proviso that: y=x+z; A is selected from Mg, Ca, Sr and Ba; B is selected from Li, Na, K. Rb and Cs; B* is selected from Li, Na and K; and preferably B and B* are not the same. Additionally, Ln 1 is selected from praseodymium (Pr), erbium (Er), and neodymium (Nd); and Ln 2 is gadolinium (Gd). The phosphor, as a result of an aftertreatment, includes at least one material which has a band gap of greater than 6.0 electronvolts (eV) and is hydrolysis-stable.

Claims (56)

1 . A water-based curable composition for the production of coatings having an antimicrobial property, the composition comprising:

at least one film-forming polymer,

optionally, at least one additive,

optionally, at least one curing agent, and

at least one up-conversion phosphor of the general formula (IIa)

Ca 1-2b Pr b Na b Li 2 SiO 4   (IIa)

wherein b=0.0001 to 0.5000;

wherein the at least one up-conversion phosphor, as a result of an aftertreatment, includes at least one material which has a band gap of greater than 6.0 electronvolts (eV) and is hydrolysis-stable and preserves an up-conversion emission of the phosphor in aqueous environments.

2 . The composition according to claim 1 , wherein the at least one material has a band gap of at most 12 electronvolts (eV).

3 . The composition according to claim 1 , wherein the at least one material is selected from the group consisting of an oxide, a silicate, a borate, a phosphate of an inorganic material, and a mixture thereof.

4 . The composition according to claim 1 , wherein the at least one material is selected from the group consisting of SiO 2 , α—Al 2 O 3 , MgO, MgAl 2 O 4 , a Ca polyphosphate, a Sr polyphosphate, a Ca or Sr pyrophosphate (Ca 1-x Sr x ) 3 P 2 O 7 wherein x=0.0 to 1.0, and a mixture thereof.

5 . The composition according to claim 1 , wherein the at least one material has been formed on the at least one up-conversion phosphor, as a result of the aftertreatment with a starting material.

6 . The composition according to claim 5 , wherein the starting material is a tetraalkyl orthosilicate, in which the alkyl groups, on each occurrence, have 1 to 10 carbon atoms.

7 . The composition according to claim 5 , wherein the starting material is selected from the group consisting of tetramethyl orthosilicate, tetraethyl orthosilicate, tetra-n-propyl orthosilicate, tetraisopropyl orthosilicate, tetrabutyl orthosilicate, and a mixture thereof.

8 . The composition according to claim 1 , wherein the at least one up-conversion phosphor, after the aftertreatment, has a crystalline core with a glass-forming or amorphous coat.

9 . The composition according to claim 1 , wherein the at least one up-conversion phosphor, prior to the aftertreatment, has been prepared with at least one flux.

10 . The composition according to claim 9 , wherein the at least one flux is at least one substance selected from the group consisting of an ammonium halide, an alkali metal halide, an alkaline earth metal halide, and a lanthanoid halide.

11 . The composition according to claim 10 , wherein the ammonium halide, the alkali metal halide, the alkaline earth metal halide, and the lanthanoid halide comprises a halide selected from the group consisting of fluoride, bromide, and chloride.

12 . The composition according to claim 10 , wherein an alkali metal of the alkali metal halide is potassium, sodium, or lithium.

13 . The composition according to claim 10 , wherein a lanthanoid of the lanthanoid halide is praseodymium.

14 . The composition according to claim 10 , wherein an alkaline earth metal of the alkaline earth metal halide is calcium or strontium.

15 . The composition according to claim 1 , wherein the at least one up-conversion phosphor is a crystalline silicate or consists of crystalline silicates doped with lanthanoid ions, wherein the at least one up-conversion phosphor comprises at least one alkali metal ion and at least one alkaline earth metal ion.

16 . The composition according to claim 1 , wherein the at least one up-conversion phosphor is at least partially crystalline.

17 . A water-based curable composition for the production of coatings having an antimicrobial property, the composition comprising:

at least one film-forming polymer,

optionally, at least one additive,

optionally, at least one curing agent, and

at least one up-conversion phosphor of the general formula (IIa)

Ca 1-2b Pr b Na b Li 2 SiO 4   (IIa)

wherein b=0.0001 to 0.5000;

wherein the at least one up-conversion phosphor, as a result of an aftertreatment, includes at least one material which has a band gap of greater than 6.0 electronvolts (eV) and is hydrolysis-stable.

18 . The composition according to claim 1 , wherein the at least one up-conversion phosphor is Ca 0.98 Pr 0.01 Na 0.01 Li 2 SiO 4 or Ca 0.94 Pr 0.03 Na 0.03 Li 2 SiO 4 .

19 . The composition according to claim 10 , wherein the at least one up-conversion phosphor includes a halogen corresponding to a halide of the at least one flux.

20 . The composition according to claim 1 , wherein the at least one up-conversion phosphor which, on irradiation with electromagnetic radiation having lower energy and longer wavelength in the range from 2000 to 400 nm, emits electromagnetic radiation having higher energy and shorter wavelength in the range from 400 to 100 nm, where an intensity of an emission maximum of the electromagnetic radiation having higher energy and shorter wavelength is an intensity of at least 1·10 3 counts/(mm 2* s).

21 . The composition according to claim 17 , wherein the at least one up-conversion phosphor according to formula (IIa) has XRPD reflections in a range from 23° 2θ to 27° 2θ and from 34° 2θ to 39.5° 2θ.

22 . The composition according to claim 1 , wherein the at least one film-forming polymer contains functional groups that are reactive with an isocyanate-containing curing agent or with a catalyst.

23 . The composition according to claim 1 , wherein the at least one film-forming polymer is selected from the group consisting of a hydroxy-functional acrylate polymer, a hydroxy-functional polyester polymer, a hydroxy-functional polyether polymer, a hydroxy-functional cellulose derivative, an amino-functional aspartic polymer, and a polyester polymer, and

wherein the at least one film-forming polymer is capable of reacting with an isocyanate-containing curing agent.

24 . The composition according to claim 1 , wherein the at least one film-forming polymer has low resonance.

25 . The composition according to claim 1 , wherein a transmittance of the at least one film-forming polymer is at least 75%, measured by a twin-beam UV/VIS spectrometer.

26 . The composition according to claim 1 , wherein a transmittance of the composition is at least 70%, measured by a twin-beam UV/VIS spectrometer.

27 . The composition according to claim 1 , wherein the at least one up-conversion phosphor has an average particle size of d50=0.1-50 μm, measured to ISO 13320:2020 and USP 429.

28 . The composition according to claim 1 , wherein the at least one additive is selected from the group consisting of a dispersant, a rheology aid, a levelling agent, a wetting agent, a defoamer, and a UV stabilizer.

29 . The composition according to claim 1 , wherein the at least one curing agent is selected from the group consisting of an aliphatic isocyanate and a cycloaliphatic isocyanate.

30 . The composition according to claim 1 , wherein a coating produced therefrom has antimicrobial action against bacteria, yeasts, molds, algae, parasites, spores, or viruses.

31 . The composition according to claim 1 , wherein a coating produced therefrom has antimicrobial action against pathogens of nosocomial infections, pathogenic environmental organisms, or pathogens in food and drink.

32 . A phosphor, wherein the phosphor is

a compound of formula (IIa),

Ca 1-2b Pr b Na b Li 2 SiO 4   (IIa)

wherein in formula (IIb), b=0.0001 to 0.5000; and

wherein the phosphor has a crystalline core with a glass-forming coat.

33 . The phosphor according to claim 32 , wherein the glass-forming coat consists of a material having a band gap of greater than 6.0 electronvolts (eV).

34 . The phosphor according to claim 33 , wherein the glass-forming coat consists of a material having a band gap of less than 12.0 electronvolts (eV).

35 . The phosphor according to claim 33 , wherein the material is selected from the group consisting of an oxide, a silicate, a borate, a phosphate of an inorganic material, and a mixture thereof.

36 . The phosphor according to claim 33 , wherein the material is selected from the group consisting of SiO 2 , α—Al 2 O 3 , MgO, MgAl 2 O 4 , a Ca polyphosphate, a Sr polyphosphate, a Ca or Sr pyrophosphate (Ca 1-x Sr x ) 3 P 2 O 7 wherein x=0.0-1.0, and a mixture thereof.

37 . The phosphor according to claim 32 , wherein the crystalline core has been produced with at least one flux.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2022
From: SCHULTE, SIMONE; HALLACK, MARKUS; HUTH, MICHAEL; TSCHERNJAEW, JURI; FISCHER, STEFAN; JÜSTEL, THOMAS; SCHRÖDER, FRANZISKA; REETZ, SVEN
To: EVONIK OPERATIONS GMBH
Reel/Frame 059902/0589 →
Priority Claims (1)
EP 21167981 · Apr 13, 2021 · regional
Continuity (1)
Related Publication 20220325176A1 · Oct 13, 2022
References Cited (48)
US 5843566A · Miyauchi · 1998 [cited by examiner]
US 6794445B2 · Reusmann et al. · 2004 [cited by applicant]
US 8524261B2 · Schmidt et al. · 2013 [cited by applicant]
US 10308820B2 · Duerr et al. · 2019 [cited by applicant]
US 11713400B2 · Schulte · 2023 [cited by examiner]
US 20030198819A1 · Reusmann et al. · 2003 [cited by applicant]
US 20060108910A1 · Justel et al. · 2006 [cited by applicant]
US 20090130169A1 · Bernstein · 2009 [cited by applicant]
US 20130224071A1 · Bernstein · 2013 [cited by applicant]
US 20140131619A1 · Greuel et al. · 2014 [cited by applicant]
US 20140161975A1 · Takanashi et al. · 2014 [cited by applicant]
US 20150329771A1 · Danielec et al. · 2015 [cited by applicant]
US 20180100071A1 · Duerr et al. · 2018 [cited by applicant]
US 20180311355A1 · Oldham · 2018 [cited by examiner]
US 20210144994A1 · Winkler et al. · 2021 [cited by applicant]
US 20210253889A1 · Schulte et al. · 2021 [cited by applicant]
US 20210403753A1 · Schulte et al. · 2021 [cited by applicant]
US 20220041887A1 · Roland et al. · 2022 [cited by applicant]
US 20220325177A1 · Schulte et al. · 2022 [cited by applicant]
US 20220403239A1 · Fischer et al. · 2022 [cited by applicant]
US 20230295495A1 · Schulte et al. · 2023 [cited by applicant]
US 20230295496A1 · Schulte et al. · 2023 [cited by applicant]
CN 1678713A · 2005 [cited by applicant]
DE 102015102427 · 2016 [cited by applicant]
EP 3020277 · 2016 [cited by applicant]
JP 2012165290A1 · 2015 [cited by applicant]
JP 2016035062A · 2016 [cited by applicant]
JP 2021165368A · 2021 [cited by applicant]
WO 2009064845 · 2009 [cited by applicant]
WO 2014184038 · 2014 [cited by applicant]
WO 2014187769 · 2014 [cited by applicant]
WO 2019197076 · 2019 [cited by applicant]
WO 2021073914 · 2021 [cited by applicant]
WO 2021073915 · 2021 [cited by applicant]
WO 2022218662 · 2022 [cited by applicant]
WO 2022218663 · 2022 [cited by applicant]
Ran et al., “Enhanced UV-Blocking Capabilities of Polylactic Acid Derived from Renewable Sources for Food and Drug Packaging: A Mini Review”, Journal of Composites Science, 7, 10, 18 pages. (Year: 2023). [cited by examiner]
U.S. Pat. No. 6,794,445, Sep. 21, 2004, 2003/0198819, Reusmann et al. [cited by applicant]
U.S. Pat. No. 10,308,820, Jun. 4, 2019, 2018/0100071, Duerr et al. [cited by applicant]
U.S. Appl. No. 17/176,922, filed Feb. 16, 2021, 2021/0253889, Schulte et al. [cited by applicant]
U.S. Appl. No. 17/395,616, filed Aug. 6, 2021, 2022/0041887, Roland et al. [cited by applicant]
U.S. Appl. No. 17/355,385, filed Jun. 23, 2021, 2021/0403753, Schulte et al. [cited by applicant]
U.S. Appl. No. 17/658,681, filed Apr. 11, 2022, 2022/0325177, Schulte et al. [cited by applicant]
Extended European Search Report dated Sep. 30, 202, in European Patent Application No. 21167981.6, 10 pages. [cited by applicant]
Kang et al., “Eu-doped barium strontium silicate phosphor particles prepared from spray solution containing NH [cited by applicant]
Office Action received for U.S. Appl. No. 17/754,783, mailed on Aug. 12, 2025, 16 pages. [cited by applicant]
Office Action received for U.S. Appl. No. 17/754,783, mailed on Apr. 22, 2025, 17 pages. [cited by applicant]
U.S. Appl. No. 17/754,783, filed Apr. 12, 2022, Fischer et al. [cited by applicant]